story of the week
Effect of Treatment With SGLT2 Inhibitors on the Risk of Amputation and Peripheral Artery Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A meta-analysis of randomized controlled studies examining the effects of sodium-glucose co-transporter-2 inhibitors on peripheral artery disease and risk of amputations
Diabetes Obes Metab 2024 Sep 12;[EPub Ahead of Print], L Geng, B Sun, Y ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.